LOXL2 and neoplasm: We also do not take into account other mechanisms whereby LOXL2 (or other Lysyl Oxidases) can enhance tumor aggressiveness; these certainly include angiogenesis [61], pre-metastasis niche formation [62], drug resistance [63] and the growth of lymphatic vessels [64] at least partially due to upregulation of VEGF.